天際股份(002759.SZ):擬將“3萬噸六氟磷酸鋰、6000噸高純氟化鋰等新型電解質鋰鹽及一體化配套項目”延期至2025年12月
格隆匯12月30日丨天際股份(002759.SZ)公佈,公司於2024年12月30日召開第五屆董事會第十一次會議、第五屆監事會第八次會議,審議通過了《關於募投項目延期的議案》,同意公司在募投項目實施主體、實施方式、建設內容、募集資金投資用途及投資規模不發生變更的前提下,將“3萬噸六氟磷酸鋰、6000噸高純氟化鋰等新型電解質鋰鹽及一體化配套項目”達到預定可使用狀態日期延期至2025年12月。本次募投項目延期事項在董事會的審批權限範圍,無需提交股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.